Clincosm LogoSign in Get a demo

immunogenicity

Showing 1 - 23 of 23
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Immunogenicity, Safety Trial (Phase II:SWIM816;SARS-Cov-2;, Phase II:SW-BIC-213;SARS-Cov-2;, PhaseIII:SWIM816;SARS-Cov-2;)

Not yet recruiting
  • Immunogenicity
  • Safety
  • Phase II:SWIM816;SARS-Cov-2;
  • +3 more
  • (no location specified)
Jun 18, 2023

Immunogenicity, Safety, Efficacy Trial in Savannakhét (SW-BIC-213;SARS-Cov-2., Sinopharm (BIBP);SARS-Cov-2.,

Active, not recruiting
  • Immunogenicity
  • +2 more
  • SW-BIC-213;SARS-Cov-2.
  • +2 more
  • Savannakhét, Sava, Lao People's Democratic Republic
    Savannakhét Provincial hospital
Jan 8, 2023

COVID-19 Pandemic, Immunogenicity, SARS CoV 2 Infection Trial in Ramat-Gan (mRNA-1273.214 Vaccine, MRNA-1273 Vaccine, Placebo)

Recruiting
  • COVID-19 Pandemic
  • +3 more
  • mRNA-1273.214 Vaccine
  • +2 more
  • Ramat-Gan, Israel
    Sheba Medical Center
Oct 26, 2022

Immunogenicity, Efficacy, Safety Trial in Savannakhét (SW-BIC-213, SARS-Cov-2 Vaccina(Vero Cell ) Inactivated)

Recruiting
  • Immunogenicity
  • +2 more
  • SW-BIC-213
  • SARS-Cov-2 Vaccina(Vero Cell ) Inactivated
  • Savannakhét, Sava, Lao People's Democratic Republic
    Savannakhét Provincial hospital
Oct 11, 2022

Rheumatic Disease, HIV, AIDS Trial in São Paulo (CoronaVac)

Active, not recruiting
  • Rheumatic Disease
  • +5 more
  • CoronaVac
  • São Paulo, SP, Brazil
    University of Sao Paulo General Hospital
May 24, 2022

Immunogenicity, Safety Trial in Bandung (Recombinant Hepatitis B + DTP-HB-Hib, Hep B + Pentabio (registered))

Completed
  • Immunogenicity
  • Safety
  • Recombinant Hepatitis B + DTP-HB-Hib
  • Hep B + Pentabio (registered)
  • Bandung, West Java, Indonesia
  • +2 more
Jan 13, 2022

Safety Issues, Immunogenicity Trial in Jakarta (Vi-DT Typhoid Conjugate Vaccine, PQed Typhoid Conjugate Vaccine, Vi

Completed
  • Safety Issues
  • Immunogenicity
  • Vi-DT Typhoid Conjugate Vaccine
  • +2 more
  • Jakarta, Jakart, Indonesia
    Jatinegara Primary Health Care
Dec 30, 2021

Gut Microbiota, Potential Key to Modulating Humoral

Recruiting
  • Microbiome
  • +4 more
  • This is observational study
  • Seoul, Korea, Republic of
    Koera University Guro Hospital
Dec 8, 2021

Pregnant and Lactating Individuals & Newborns COVID-19

Recruiting
  • SARS-CoV2 Infection
  • +4 more
    • Hamilton, Ontario, Canada
    • +6 more
    Nov 8, 2021

    Covid-19, Vaccine, Immunogenicity Trial in Taoyuan (Heterologous prime-boost schedule with AZD1222 and MVC-COV1901, Homologous

    Recruiting
    • Covid-19
    • +4 more
    • Heterologous prime-boost schedule with AZD1222 and MVC-COV1901
    • Homologous prime-boost schedule with two doses of AZD1222
    • Taoyuan, Taiwan
      ChangGungMH
    Oct 19, 2021

    Immunogenicity of Covid-19 Vaccination for Hematological

    Active, not recruiting
    • Immunogenicity
    • +3 more
      • Varese, Lombardia, Italy
        UOC Ematologia, ASST Sette Laghi, Osp. Di Circolo e Fondazione M
      Sep 10, 2021

      Immunogenicity of the ChAdox1 n CoV-19 Vaccine With 12-dose Vial

      Completed
      • Covid19
      • +2 more
      • Immunogenicity after first dose of participants who received first dose of ChAdox-1 n COV-19 vaccine
      • Bangkok, Thailand
        Thananda Trakarnvanich
      Jul 13, 2021

      Safety, Immunogenicity Trial in Entebbe, Oxford (ChAdOx185A, MVA85A, BCG)

      Active, not recruiting
      • Safety
      • Immunogenicity
      • ChAdOx185A
      • +2 more
      • Entebbe, Uganda
      • +1 more
      May 13, 2021

      Immunogenicity Trial in Semarang (Recombinant Hepatitis B vaccine, Recombinant Hepatitis B (Bio Farma))

      Completed
      • Immunogenicity
      • Recombinant Hepatitis B vaccine
      • Recombinant Hepatitis B (Bio Farma)
      • Semarang, Central Java, Indonesia
        RSND
      Mar 30, 2020

      Safety Issues, Immunogenicity Trial in Jakarta (Vi-DT Vaccine, Vi Polysaccharide Vaccine, IPV Vaccine)

      Completed
      • Safety Issues
      • Immunogenicity
      • Vi-DT Vaccine
      • +2 more
      • Jakarta, Indonesia
      • +1 more
      Feb 18, 2020

      Immunogenicity, Shigellosis Trial in Petach Tikva (Shigella Sonnei O-SPC/rBRU)

      Completed
      • Immunogenicity
      • Shigellosis
      • Shigella Sonnei O-SPC/rBRU
      • Petach Tikva, Israel
        Schneider Children's Hospital
      Dec 13, 2019

      Immunogenicity, Healthy Volunteers Trial in Ahmedabad (INTP5, US Neulasta)

      Completed
      Has Results
      • Immunogenicity
      • Healthy Volunteers
      • INTP5
      • US Neulasta
      • Ahmedabad, Gota, India
        Lambda Therapeutic Research Ltd.
      Sep 13, 2019

      Safety Issues, Immunogenicity Trial in Surabaya (Measles-Rubella (MR) Vaccine)

      Completed
      • Safety Issues
      • Immunogenicity
      • Measles-Rubella (MR) Vaccine
      • Surabaya, East Java, Indonesia
        Child Health Dept. Dr. Soetomo Hospital, School of Medicine Airl
      Sep 10, 2019

      Congenital Cytomegalovirus inHigh HIV Prevalence Setting, South

      Completed
      • Cytomegalovirus Congenital
      • +5 more
        • Johannesburg, South Africa
          Respiratory and Meningeal Pathogen Research Unit, Soweto
        Aug 4, 2019

        Gardasil Vaccine, Stem Cell Transplant, Immunogenicity Trial run by the NHLBI (Gardasil)

        Completed
        Has Results
        • Gardasil Vaccine
        • +2 more
        • Gardasil
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        Jul 25, 2019

        Vaccines, HIV, Safety Trial in Maputo, Dar es Salaam, Mbeya (HIVIS DNA vaccine, Zetajet, Derma Vax Electroporation)

        Completed
        • Vaccines
        • +3 more
        • HIVIS DNA vaccine
        • +3 more
        • Maputo, Mozambique
        • +2 more
        Jun 26, 2015

        Immunogenicity, Reactogenicity Trial in Bangkok (Trivivac vaccine)

        Unknown status
        • Immunogenicity
        • Reactogenicity
        • Trivivac vaccine
        • Bangkok, Thailand
          Queen Sirikit National Institute of Child Health
        Jan 5, 2013

        Immunogenicity, Safety Trial in Nanjing (160U /0.5ml EV71 Vaccine, 320U /0.5ml EV71 vaccine, 640U /0.5ml EV71 vaccine)

        Completed
        • Immunogenicity
        • Safety
        • 160U /0.5ml EV71 Vaccine
        • +4 more
        • Nanjing, Jiangsu, China
          Jiangsu Provincial Center for Diseases Control and Prevention
        May 29, 2012